New RA drug enters human safety testing
NCT ID NCT07433335
First seen Mar 02, 2026 · Last updated May 11, 2026 · Updated 10 times
Summary
This early-stage study tests a new medicine called SR-878 in 27 adults with rheumatoid arthritis. The goal is to find a safe dose by checking for side effects. Participants will take the drug once and be monitored for about 16 weeks. This is not a cure; it aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SciRhom clinical trial site
NOT_YET_RECRUITINGTbilisi, Georgia
-
SciRhom clinical trial site
RECRUITINGChisinau, Moldova
-
SciRhom clinical trial site
NOT_YET_RECRUITINGBucharest, Romania
-
SciRhom clinical trial site
NOT_YET_RECRUITINGCluj-Napoca, Romania
Conditions
Explore the condition pages connected to this study.